Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation.

Men Y, Wang C, Popoola DO, Cao Z, Tian W, Cooney RN, Meng Q, Li Y

Open source

DOI
10.3389/fimmu.2026.1821659
Published
2026
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1821659,
  title = {Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation.},
  author = {Men Y and Wang C and Popoola DO and Cao Z and Tian W and Cooney RN and Meng Q and Li Y},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1821659},
  url = {https://doi.org/10.3389/fimmu.2026.1821659}
}

RIS

TY  - JOUR
TI  - Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation.
AU  - Men Y
AU  - Wang C
AU  - Popoola DO
AU  - Cao Z
AU  - Tian W
AU  - Cooney RN
AU  - Meng Q
AU  - Li Y
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1821659
UR  - https://doi.org/10.3389/fimmu.2026.1821659
ER  - 

APA

Y, M., C, W., DO, P., Z, C., W, T., RN, C., Q, M., & Y, L. (2026). Lung-specific sulfonium lipid nanoparticle formulation of dexamethasone suppresses endotoxin-induced lung inflammation.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1821659

Source records